Related Experiment Video
Updated: May 18, 2026
Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
Published on: March 16, 2018
BDNF as otoprotectant in toxin-induced hearing loss
Adnan Lidian1, Birgitta Linder, Matti Anniko
1Department of Oto-Rhino-Laryngology and Head & Neck Surgery, University Hospital (Akademiska sjukhuset), Uppsala, Sweden. adnan.lidian@akademiska.se
Conclusion:
Brain-derived neurotrophic factor (BDNF) can prevent auditory brainstem response (ABR) threshold shift changes caused by Pseudomonas aeruginosa exotoxin A (PaExoA).
Objective:
Peptides of the neurotrophin family are known to prevent neuronal death during embryonic development by interacting with specific membrane receptors. The purpose of this study was to investigate whether a single dose of BDNF is an effective protectant against toxic effects of PaExoA-induced ABR threshold shifts.
Materials And Methods:
Eight groups of Sprague-Dawley rats were used. There were five control groups (n = 20) as follows. Group A (n = 4) received NaCl solution; group B (n = 3) received 4 µg BDNF; group C (n = 4) received 1 μg/20 μl PaExoA; group D (n = 4) received 2 μg/20 μl PaExoA; group E (n = 5) received 10 µg/20 µl PaExoA injected into the round window niche. Three treatment groups (n = 13) received a single dose of PaExoA and 4 µg of BDNF simultaneously. Group 1 (n = 3) received 1 μg/20 μl PaExoA + 4 µg of BDNF; group 2 (n = 5) received 2 μg/20 μl PaExoA + 4 µg BDNF; group 3 (n = 5) received 10 μg/20 μl PaExoA + 4 µg BDNF. ABR was used to measure efficacy by analyzing threshold shifts before and after injections.
Results:
A single dose of BDNF prevented changes in ABR thresholds following exposure to increasing concentrations of PaExoA injected into the middle ear.
